CHARLES M. BAUM - 16 May 2022 Form 3 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Director
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Issuer symbol
PSTX
Transactions as of
16 May 2022
Transactions value $
$0
Form type
3
Filing time
18 May 2022, 16:30:02 UTC
Previous filing
18 Jan 2022
Next filing
06 Jun 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.